Commuters are inhaling unacceptably high levels of carcinogens
Twenty minutes or longer in the car also raises risk of birth defects
A new study finds that California's commuters are likely inhaling chemicals at levels that increase the risk for cancer and birth defects.

Driver exercising extreme caution in his car.
Stan Lim/UCR
As with most chemicals, the poison is in the amount. Under a certain threshold of exposure, even known carcinogens are not likely to cause cancer. Once you cross that threshold, the risk for disease increases.
Governmental agencies tend to regulate that threshold in workplaces. However, private spaces such as the interior of our cars and living rooms are less studied and less regulated.
Benzene and formaldehyde -- both used in automobile manufacturing -- are known to cause cancer at or above certain levels of exposure and are Prop. 65-listed chemicals.
New UC Riverside research shows that the average commuter in California is exceeding the threshold for exposure, breathing in unsustainably high levels of both chemicals.
Both benzene and formaldehyde are carcinogens, and benzene carries the additional risk of reproductive and developmental toxicity.
"These chemicals are very volatile, moving easily from plastics and textiles to the air that you breathe," said David Volz, UCR professor of environmental toxicology.
The study, published in the journal Environment International, calculated the daily dose of benzene and formaldehyde being inhaled by drivers with commutes of at least 20 minutes per day.
It found that up to 90% of the population in Los Angeles, San Diego, Orange, Santa Clara, and Alameda counties have at least a 10% chance of exceeding cancer risk from inhaling the chemicals, based on having 30-minute average commute times.
"Of course, there is a range of exposure that depends on how long you're in the car, and how much of the compounds your car is emitting," said Aalekhya Reddam, a graduate student in the Volz laboratory, and lead author of the study.
Previously, Volz and Reddam studied commuter exposure to a flame retardant called TDCIPP or chlorinated tris, and found that longer commute times increased exposure to that carcinogen as well.
They set out on this study wanting to understand the risk of that compound relative to other chemicals introduced during car manufacturing.
Reddam advises commuters to keep the windows open during their rides if possible. "At least with some air flow, you'd be diluting the concentration of these chemicals inside your car," she said.
Benzene is used to produce synthetic fibers, and formaldehyde is a binder in plastics. "There should be alternatives to these chemicals to achieve the same goals during vehicle manufacturing," Volz said. "If so, these should be used."
Original publication
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Artificial intelligence to help protect bees from pesticides - Researchers develop computer model to predict whether a pesticide will harm bees
Coronary_circulation
Menstrual_disorder
Ilya_Ilyich_Mechnikov
Cerebral_hypoxia

New technology taps power of diatoms to dramatically improve sensor performance
Hsp90
Albuminuria
YM Bioscience reports Phase II data for nimotuzumab in metastatic colorectal cancer - Overall Survival And Disease Control Outcomes, Coupled With Low Toxicity, Support The Continued Development Of The EGFR Antibody In Patients With Colorectal Cancer

Hong Kong firm invests in Jena-based Oncgnostics GmbH
